Fee for Service

Business Model

IDRS extends its services to pharmaceutical organizations on a fee-for-service model. In this model, a contract is signed for drug product development service and project is tracked as per milestones.

Project Overlook

IDRS maintains proven track record in Fee-for-Service projects completed so far. Projects approved and launched in the US market had not received any critical observations from the regulatory agencies on the development aspects.
COVID Update
Team IDRS is committed towards working on complex products in niche therapeutic areas to address the unmet medical needs. This extends to the current challenging time, where the entire scientific community is working towards bringing some therapeutic option to provide relief from Covid-19 and associated complications. Our team, in collaboration with some of the premier Indian Institutes, is fervently working on a phytopharmaceutical product that will not only provide an option to treat Covid 19 patients but also minimise post Covid complications. Watch this space for further updates.